Women's Cancer News
Dec. 18, 2013

Global cancer deaths rise to 8.2 million
The global death toll from cancer rose to 8.2 million in 2012 with sharp rises in breast cancer as the disease tightened its grip in developing nations struggling to treat an illness driven by Western lifestyles. Cancer deaths were up 8 percent from 7.6 million in a previous survey in 2008 and breast cancer killed 522,000 women last year, up 14 percent in the same period, according to the World Health Organization's International Agency for Research on Cancer.More

US cancer death rates continue to decline
HealthDay News via WebMD
Cancer death rates continue to decline in the United States, mainly because anti-smoking efforts have caused a drop in lung cancer deaths, researchers report. From 2001 through 2010, death rates for all cancers combined decreased by 1.8 percent a year among men and by 1.4 percent a year among women, according to a joint report from four of the nation's top cancer institutions, published Dec. 16 in the journal Cancer.More

Study shows families don't understand genetic test results or their implications
Medical Xpress
A study done by researchers at Fox Chase Cancer Center shows that many relatives of patients who undergo testing for a gene linked to breast and ovarian cancers misinterpret the results, and less than half of those who could benefit from genetic testing say they plan to get tested themselves — despite the fact that knowing your genetic status may help catch the disease in its earliest stages. More

Don't count on insurance to pay for genetic tests
The day when a simple blood test or saliva sample can identify your risk for medical conditions ranging from cancer to Alzheimer's disease seems tantalizingly close. But genetics specialists say the hype around many of these tests has outstripped the science. Insurers generally only cover a test if there's strong scientific evidence that it can provide a health benefit to patients.More

2 existing drugs show promise as potential treatments for cervical cancer
Two existing drugs — one the active ingredient in an anti-fungal medication and the other now used to control iron levels in the blood — both show promise as potential treatments for cervical cancer, according to newly published research by scientists at Rutgers New Jersey Medical School.More

Evidence mounts for endometrial cancer tumor testing to identify women with Lynch Syndrome
A recent article by Norris Cotton Cancer Center researchers published in the January 2014 issue of the journal Clinical Chemistry reviews the scientific evidence that warrants screening all endometrial cancers for Lynch syndrome. Next to colorectal cancer, endometrial cancer is the most common form of cancer in women with Lynch syndrome. Currently at Dartmouth-Hitchcock Medical Center, every colon cancer specimen is screened for Lynch syndrome via specialized tumor testing. There is mounting evidence that this special tumor testing should also be done on every endometrial cancer specimen. This tumor testing, known as immunohistochemistry and microsatellite instability, gives clinicians some preliminary information to see if Lynch syndrome played a role in the development of their patient's cancer.More

Spontaneous fusion with macrophages empowers cancer cells to spread
Cancer cells that spontaneously fuse with macrophages, the immune system's healthy scavenger cells, play a key role in the metastasis, or spread of the cancer to other areas of the body, according to research to be presented at the American Society for Cell Biology annual meeting in New Orleans.More

Rutgers team delivers RNA to weaken drug-resistant ovarian cancer
Rutgers University
In a new study published in Clinical Cancer Research, Rutgers University researchers provide results of animal research in which ovarian cancer is attacked at the genetic level by using small, inhibiting RNA molecules that directly target and decrease the excess CD44 protein in cancer cells while simultaneously treating patients with the anti-cancer drug paclitaxel. This allows cells within the cancerous tumors to be successfully treated even at an advanced stage.More

Furthering the conversation on the HPV vaccine
The Huffington Post
Article by Katie Couric: Last week we devoted several segments on my TV talk show to the issues surrounding the HPV vaccine. Learning about this relatively recent preventive measure is tremendously important, and I felt it was a subject well worth exploring. Following the show, and in fact before it even aired, there was criticism that the program was too anti-vaccine and anti-science, and in retrospect, some of that criticism was valid. More